Bronchiectasis is not contagious. It is a structural lung condition, not an infection, so it cannot spread from one person to another through coughing, physical contact, or any other route. The condition involves permanent widening and damage to the airways, which is something that develops inside an individual’s lungs over time due to inflammation or repeated infections.
That said, the question makes sense. Bronchiectasis often involves chronic bacterial infections and produces a lot of coughing and mucus, which can look and sound like a transmissible illness. The reality is more nuanced than a simple yes or no, because while bronchiectasis itself isn’t contagious, some of the bacteria living in damaged airways deserve a closer look.
Why Bronchiectasis Itself Can’t Spread
Bronchiectasis is defined by permanent, abnormal dilation of the bronchi, the tubes that carry air through your lungs. In a healthy airway, elastic tissue, muscle, and cartilage keep these tubes firm and springy. In bronchiectasis, chronic inflammation triggers immune cells (primarily neutrophils) to release enzymes that break down elastin, muscle, and cartilage in the airway walls. Over time, the airways become floppy, stretched out, and unable to clear mucus effectively.
This structural damage is the disease. It’s not caused by a single germ that could jump to someone else. It develops because of a cycle: mucus pools in the widened airways, bacteria colonize that mucus, the immune system responds with more inflammation, and the inflammation causes further damage. The cycle is internal and specific to that person’s lungs.
What Actually Causes It
The most common trigger is repeated or severe lung infections, particularly in childhood. A bad bout of pneumonia, whooping cough, or tuberculosis can leave enough scarring to start the cycle of damage. Inhaling a foreign object as a child is another classic cause.
Beyond infections, a wide range of conditions can lead to bronchiectasis:
- Cystic fibrosis, which produces abnormally thick mucus that clogs the airways
- Primary ciliary dyskinesia, a genetic condition where the tiny hair-like structures that sweep mucus out of the lungs don’t work properly
- Immune deficiency syndromes, which leave the lungs vulnerable to repeated infections
- Autoimmune disorders like rheumatoid arthritis, Sjögren syndrome, or inflammatory bowel disease
- Allergic lung diseases
In many cases, no specific cause is ever identified. The condition is increasingly common: a recent meta-analysis covering more than 437 million participants estimated a pooled prevalence of about 680 per 100,000 people, with rates rising in multiple countries over the past decade.
The Bacteria That Live in Damaged Airways
Here’s where the picture gets slightly more complicated. People with bronchiectasis often have bacteria chronically living in their airways. The most common include Pseudomonas aeruginosa, Haemophilus influenzae, and sometimes nontuberculous mycobacteria (NTM). These organisms thrive in the stagnant mucus that pools in damaged airways.
For the general public, this poses essentially no risk. These are opportunistic bacteria, meaning they cause problems mainly in people whose lungs are already compromised. A healthy person sitting next to someone with bronchiectasis is not going to “catch” the condition.
The one scenario where transmission matters is between patients who already have damaged lungs. UK-based studies have found a small risk of Pseudomonas aeruginosa spreading between bronchiectasis patients, and between cystic fibrosis patients and bronchiectasis patients, particularly during hospital stays or shared physiotherapy sessions. One case report described likely transmission of Pseudomonas to a bronchiectasis patient who had shared accommodation and physiotherapy with cystic fibrosis patients. The overall risk appears low, but it’s real enough that infection control practices in clinical settings are taken seriously.
NTM bacteria, which can cause a particularly stubborn type of lung infection in bronchiectasis patients, don’t typically spread person to person at all. According to the CDC, NTM is found naturally in soil, dust, and water. People pick it up from the environment, often by inhaling aerosolized water from things like showerheads or hot tubs, not from other people.
What Bronchiectasis Feels Like Day to Day
The hallmark symptom is a persistent cough that produces significant amounts of mucus, often daily. The mucus can range from clear to yellow or green, and the volume tends to increase during flare-ups. Breathlessness, fatigue, and occasionally coughing up small amounts of blood are also common.
Flare-ups (called exacerbations) happen when symptoms worsen noticeably for at least 48 hours. During an exacerbation, you might notice more mucus than usual, a change in its color or thickness, increased breathlessness, deeper fatigue, or general malaise. These episodes typically require a change in treatment, often a course of antibiotics.
How It’s Diagnosed
Bronchiectasis is confirmed with a high-resolution CT scan of the chest. On the scan, doctors look for airways that are visibly wider than the blood vessel running alongside them. In healthy lungs, an airway and its companion artery are roughly the same diameter. In bronchiectasis, the airway may be two, three, or even four times wider than normal. The condition is categorized into three patterns based on appearance: tubular (smooth widening), varicose (widening with irregular indentations), and cystic (widened airways ending in sac-like pouches).
Managing the Condition
Because the airway damage is permanent, treatment focuses on slowing progression, preventing infections, and keeping the airways as clear as possible. The cornerstone of daily management is airway clearance, a set of physical techniques designed to help mucus drain out of the lungs. These include specific breathing exercises, controlled coughing (called “huffing”), gravity-assisted positioning, and handheld devices that create vibrations or back-pressure as you exhale through them.
Most treatment plans call for airway clearance twice daily, with each session lasting 20 to 30 minutes. Some protocols use sessions four times daily during flare-ups. The specific technique varies from person to person, and a respiratory physiotherapist typically helps find what works best. Studies have shown that consistent use of these techniques improves cough-related quality of life over periods of three months or longer.
Preventing new infections is equally important. People with bronchiectasis are more vulnerable to respiratory infections than the general population, and each new infection can accelerate lung damage. Staying current on vaccinations, practicing good hand hygiene, and avoiding close contact with people who have active respiratory illnesses all help reduce that risk. In clinical settings, good infection control principles are recommended, though routine isolation of bronchiectasis patients based on their bacteria is not considered necessary according to British Thoracic Society guidelines.